Literature DB >> 17502126

Of PCSK9, cholesterol homeostasis and parasitic infections: possible survival benefits of loss-of-function PCSK9 genetic polymorphisms.

Majambu Mbikay1, Janice Mayne, Nabil G Seidah, Michel Chrétien.   

Abstract

Cholesterol is important for cell membrane structure and functions as well as for production of steroid hormones and bile acids. It is transported through the body as lipoprotein particles of varying density and composition. Cholesterol homeostasis is maintained through finely tuned mechanisms regulating dietary uptake, hepatic biosynthesis and secretion as well as plasma clearance. Proprotein convertase subtilisin/kexin type 9 (PCSK9) reduces cellular uptake of plasma low-density lipoprotein-cholesterol (LDL-C) by promoting LDL receptor (LDLR) degradation. Two nonsense single-nucleotide polymorphisms (SNPs) at the PCSK9 locus have been associated with life-long hypocholesterolemia and a remarkable reduction of the risk for coronary heart disease (CHD) in African-Americans. These loss-of-function SNPs presumably render PCSK9 less capable of inducing LDLR catabolism, effectively increasing LDLR availability and allowing efficient removal of plasma LDL-C. The combined frequency of heterozygosity for these nonsense SNPs is approximately 3-4% in populations of African descent. Homozygosity for either SNP, which would aggravate hypocholesterolemia, is reportedly rare. Whether such an aggravation would represent a health risk is still a matter of debate. From an evolutionary point of view, the cardioprotective effect of these nonsense SNPs may be a secondary phenotype made evident by the dyslipidemia-inducing lifestyle of today's North America. Their relatively high frequency in African-Americans must be interpreted in the context of the ancestral environment of these subjects in Africa, where diet and lifestyle were presumably less predisposing to atherosclerosis and where parasitic infections were major causes of morbidity and mortality before reproductive age. Parasites feed on host cholesterol for successful infection. The nonsense PCSK9 SNPs may have been positively selected because they reduced susceptibility to severe parasitic infections through cholesterol restriction. If so, these SNPs should be significantly more frequent in Sub-Saharan Africa where parasitic diseases, malaria in particular, have been and still are major selective forces.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17502126     DOI: 10.1016/j.mehy.2007.03.018

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  8 in total

1.  Forward Look: Tenth Anniversary of the Human Genome Sequence and 21 Century Postgenomics Global Health - A Close Up on Africa and Women's Health.

Authors:  Sanaa M Kamal; Louise Warnich; Lynnette R Ferguson; Sanjeeva Srivastava; Sandipan Ray; Denise Avard; Yann Joly; Michael Le Huynh; Madeline Page; Mario Masellis; Edward S Dove; David Gurwitz; Vural Ozdemir
Journal:  Curr Pharmacogenomics Person Med       Date:  2011-09-01

2.  Interethnic Variation in Lipid Profiles: Implications for Underidentification of African-Americans at risk for Metabolic Disorders.

Authors:  Amy R Bentley; Charles N Rotimi
Journal:  Expert Rev Endocrinol Metab       Date:  2014-01-10

Review 3.  Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering.

Authors:  Giuseppe Danilo Norata; Hagai Tavori; Angela Pirillo; Sergio Fazio; Alberico L Catapano
Journal:  Cardiovasc Res       Date:  2016-08-05       Impact factor: 10.787

4.  Malaria severity: Possible influence of the E670G PCSK9 polymorphism: A preliminary case-control study in Malian children.

Authors:  Charles Arama; Issa Diarra; Bourèma Kouriba; Francine Sirois; Olesya Fedoryak; Mahamadou A Thera; Drissa Coulibaly; Kirsten E Lyke; Christopher V Plowe; Michel Chrétien; Ogobara K Doumbo; Majambu Mbikay
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240

5.  PCSK9 loss-of-function variants and risk of infection and sepsis in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort.

Authors:  Kellie A Mitchell; Justin Xavier Moore; Robert S Rosenson; Ryan Irvin; Faheem W Guirgis; Nathan Shapiro; Monika Safford; Henry E Wang
Journal:  PLoS One       Date:  2019-02-06       Impact factor: 3.240

6.  Patterns and tempo of PCSK9 pseudogenizations suggest an ancient divergence in mammalian cholesterol homeostasis mechanisms.

Authors:  Barbara van Asch; Luís Filipe Teixeira da Costa
Journal:  Genetica       Date:  2021-01-30       Impact factor: 1.082

7.  Evidence for positive selection in the C-terminal domain of the cholesterol metabolism gene PCSK9 based on phylogenetic analysis in 14 primate species.

Authors:  Keyue Ding; Samantha J McDonough; Iftikhar J Kullo
Journal:  PLoS One       Date:  2007-10-31       Impact factor: 3.240

Review 8.  Insight into the Evolving Role of PCSK9.

Authors:  Mateusz Maligłówka; Michał Kosowski; Marcin Hachuła; Marcin Cyrnek; Łukasz Bułdak; Marcin Basiak; Aleksandra Bołdys; Grzegorz Machnik; Rafał Jakub Bułdak; Bogusław Okopień
Journal:  Metabolites       Date:  2022-03-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.